0 NYSE Companies - July 30, 2020RLH Corporation Announces Date of Second Quarter 2020 Financial Results and Conference CallDENVER, July 30, 2020 (GLOBE NEWSWIRE) — RLH Corporation (NYSE:RLH) announced today that it will release its second quarter 2020 […]Read More
0 NYSE Companies - July 30, 2020SPX Reports Second Quarter 2020 ResultsQ2 GAAP EPS of $0.62; Adjusted EPS* of $0.64 Balanced Portfolio Supported Strong Q2 ResultsSuccessfully Navigating COVID-19 ChallengesCHARLOTTE, N.C., July 30, […]Read More
0 NYSE Companies - July 30, 2020Intrepid Potash Announces Stockholder Approval of Reverse Split Proposals and Receipt of NYSE Continued Listing Standard NoticeDENVER, CO, July 30, 2020 (GLOBE NEWSWIRE) — Intrepid Potash Inc. (NYSE:IPI) (“Intrepid” or the “Company”) today announced that at […]Read More
0 NASDAQ Companies - July 30, 2020Kinsale Capital Group, Inc. Reports 2020 Second Quarter ResultsRICHMOND, Va., July 30, 2020 (GLOBE NEWSWIRE) — Kinsale Capital Group, Inc. (NASDAQ:KNSL) reported net income of $30.3 million, $1.33 […]Read More
0 NASDAQ Companies - July 30, 2020Ultragenyx Reports Second Quarter 2020 Financial Results and Corporate UpdateTwo U.S. FDA approvals in second quarter 2020Second quarter 2020 total revenue of $61.7 million and Crysvita revenue in Ultragenyx […]Read More
0 NASDAQ Companies - July 30, 2020Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsProvides Update on CPI-006 Phase 1 COVID-19 StudyConference Call Today at 4:30 p.m. ET / 1:30 p.m. PTBURLINGAME, Calif., July […]Read More
0 NASDAQ Companies - July 30, 2020SIGA Technologies to Host Business Update Call on August 6, 2020 Following Release of Second Quarter Financial ResultsNEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on […]Read More
0 NASDAQ Companies - July 30, 2020Optinose Announces Reporting Date for Second Quarter 2020 Financial ResultsYARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose […]Read More
0 NASDAQ Companies - July 30, 2020Retrophin Reports Second Quarter 2020 Financial ResultsEnrollment ahead of schedule in Phase 3 PROTECT Study of sparsentan in IgAN; topline proteinuria data from both pivotal studies […]Read More
0 NASDAQ Companies - July 30, 2020Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Provide Corporate UpdateBURNABY, British Columbia, July 30, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced […]Read More